See more : KISCO Corp. (104700.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Deepak Nitrite Limited (DEEPAKNI.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Deepak Nitrite Limited, a leading company in the industry within the sector.
- C’bon Cosmetics Co.,Ltd. (4926.T) Income Statement Analysis – Financial Results
- HMN Financial, Inc. (HMNF) Income Statement Analysis – Financial Results
- Brookfield Infrastructure Corpo (BIPH) Income Statement Analysis – Financial Results
- Captor Capital Corp. (CPTR.CN) Income Statement Analysis – Financial Results
- China Traditional Chinese Medicine Holdings Co. Limited (CHIZF) Income Statement Analysis – Financial Results
Deepak Nitrite Limited (DEEPAKNI.BO)
Industry: Chemicals
Sector: Basic Materials
About Deepak Nitrite Limited
Deepak Nitrite Limited manufactures and sells chemical intermediates in India and internationally. It operates through Advanced Intermediates and Phenolics segments. The company offers sodium nitrite, sodium nitrate, nitro toluidines, fuel additives, nitrosyl sulphuric acid, xylidines, oximes, cumidines, speciality agrochemicals, optical brightening agent, and diamino stilbene disulfonic acid for colourants, rubber chemicals, explosives, dyes, pigments, food colours, pharmaceuticals, diesel blending, agrochemicals, glass, personal care, paper, detergents, and textiles industries. In addition, it provides cumene, phenol, acetone, isopropyl alcohol, and AMS for various applications including laminates, ply, adhesive, paints, auto, pharmaceuticals, plastics, etc. Deepak Nitrite Limited was incorporated in 1970 and is headquartered in Vadodara, India.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|
Revenue | 79.53B | 67.81B | 43.36B | 41.96B | 26.78B |
Cost of Revenue | 64.88B | 50.95B | 30.04B | 31.23B | 21.84B |
Gross Profit | 14.66B | 16.86B | 13.32B | 10.73B | 4.94B |
Gross Profit Ratio | 18.43% | 24.86% | 30.72% | 25.57% | 18.46% |
Research & Development | 183.60M | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 3.12B | 2.58B | 2.40B | 2.01B | 1.54B |
Other Expenses | -11.80M | 26.00M | -66.30M | -64.90M | -94.79M |
Operating Expenses | 3.32B | 2.56B | 2.46B | 2.07B | 1.64B |
Cost & Expenses | 68.19B | 53.51B | 32.50B | 33.31B | 23.48B |
Interest Income | 32.10M | 21.30M | 32.90M | 21.20M | 14.78M |
Interest Expense | 266.80M | 363.70M | 773.30M | 1.16B | 785.98M |
Depreciation & Amortization | -1.66B | -1.78B | -1.53B | -1.40B | -777.93M |
EBITDA | 13.00B | 16.08B | 12.38B | 10.05B | 4.08B |
EBITDA Ratio | 16.35% | 23.71% | 28.56% | 23.95% | 15.24% |
Operating Income | 11.34B | 14.30B | 10.86B | 8.65B | 3.31B |
Operating Income Ratio | 14.26% | 21.09% | 25.04% | 20.62% | 12.34% |
Total Other Income/Expenses | 118.80M | 44.30M | -438.80M | -589.80M | -625.41M |
Income Before Tax | 11.46B | 14.34B | 10.42B | 8.06B | 2.68B |
Income Before Tax Ratio | 14.41% | 21.15% | 24.03% | 19.22% | 10.00% |
Income Tax Expense | 2.94B | 3.68B | 2.66B | 1.95B | 943.17M |
Net Income | 8.52B | 10.67B | 7.76B | 6.11B | 1.74B |
Net Income Ratio | 10.71% | 15.73% | 17.89% | 14.56% | 6.48% |
EPS | 62.46 | 78.20 | 56.88 | 44.80 | 12.73 |
EPS Diluted | 62.46 | 78.20 | 56.88 | 44.80 | 12.73 |
Weighted Avg Shares Out | 136.40M | 136.40M | 136.40M | 136.40M | 136.39M |
Weighted Avg Shares Out (Dil) | 136.40M | 136.40M | 136.40M | 136.40M | 136.39M |
Source: https://incomestatements.info
Category: Stock Reports